Brevan Howard Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $560K | Buy |
+97,688
| New | +$560K | ﹤0.01% | 1222 |
|
2025
Q1 | – | Sell |
-18,266
| Closed | -$172K | – | 1217 |
|
2024
Q4 | $172K | Sell |
18,266
-26,094
| -59% | -$246K | ﹤0.01% | 901 |
|
2024
Q3 | $474K | Buy |
44,360
+31,185
| +237% | +$333K | ﹤0.01% | 640 |
|
2024
Q2 | $131K | Buy |
+13,175
| New | +$131K | ﹤0.01% | 896 |
|
2015
Q3 | – | Sell |
-65,500
| Closed | -$927K | – | 27 |
|
2015
Q2 | $927K | Buy |
+65,500
| New | +$927K | 0.29% | 26 |
|